Top Markets
#1 Siren Siren +33.94%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.71%
#3 Ribbita by Virtuals Ribbita by Virtuals +18.13%
#4 Wiki Cat Wiki Cat +17.37%
#5 PulseChain PulseChain +16.92%
#6 Cysic Cysic +16.47%
#7 Velvet Velvet +16.43%
#8 Bitway Bitway +16.27%
#9 KUB Coin KUB Coin +15.77%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +15.36%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Lactose (India) Limited Lactose (India) Limited

Lactose (India) Limited

LACTOSE
Rank in Stocks #31237
Lactose India Ltd. specializes in the production of a wide array of... Lactose India Ltd. specializes in the production of a wide array of pharmaceutical items. Its product portfolio encompasses excipients, solid and liquid dosage forms, Active Pharmaceutical Ingredients (APIs), and prebiotic galacto-oligosaccharides. The company was established on March 11, 1991, and operates from its headquarters in Mumbai, India.
Share Price
$1.10
Market Cap
$13.84M
Change (1 day)
-3.91%
Change (1 year)
-1.66%
Country
IN
Trade Lactose (India) Limited (LACTOSE)

Category

Healthcare
Revenue for Lactose (India) Limited (LACTOSE)
Revenue in Aug 2026 TTM: 0
According to Lactose (India) Limited latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Lactose (India) Limited from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT